BEYANG Therapeutics Co., Ltd. is an innovative biopharmaceutical company that employs its proprietary ExCEED platforms to accelerate the process of new drug discovery and development in disease areas of significant unmet medical needs. Founders and management team each has more than 20 years of experience and worked at Pfizer, Merck, Astra Zeneca, Schring Plough and Hengrui previously. They are quite experienced in drug target selection, CADD, AIDD, bioassay screening and optimization, as well as DMPK. Together they have contributed to the development of more than 10 clinical candidate molecules, of which three drugs have been approved by FDA and NMPA.
Company Details
- Employees
- 4
- Founded
- 2021
- Address
- 3a01, Neo Park, No. 103 Cailun Road, Pudong New Area, Shanghai, Shanghai,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.beyangtx.com
- Keywords
- IT Consulting.
- HQ
- Shanghai
Beyang Therapeutics Questions
Beyang Therapeutics's website is http://www.beyangtx.com
Beyang Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/beyang-therapeutics
Beyang Therapeutics has
4 employees.
View email and phone details for 4
employees at Beyang Therapeutics.
Beyang Therapeutics's industry is
Pharmaceutical Manufacturing
Beyang Therapeutics's top competitors are
Hengrui Pharma,
Convergen Pharmaceuticals Co., Ltd,
Hebei Shengxue Dacheng Tangshan Pharmaceutical Co., Ltd,
米度(南京)生物技术有限公司,
Deliver Life Sciences,
Shenzhen Salubris Pharmaceuticals Co.,ltd.,
武汉百纳礼康生物制药有限公司,
Fungram Balloons (Guangzhou) Industry Limited,
兰晟生物医药（苏州）有限公司,
Locust Walk.
Beyang Therapeutics's categories are Pharmaceutical Manufacturing
Beyang Therapeutics's founding year is 2021
